secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001193125-25-087219
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zimmer Biomet completes acquisition of Paragon 28 for $13.00/share plus CVR
---------------------------------------------------------------------------

- Closing on April 21, 2025; each Paragon 28 share converted to $13.00 cash plus up to $1.00 CVR tied to revenue milestones.
- Paragon 28 becomes wholly-owned subsidiary; delisted from NYSE effective April 21, 2025.
- Deal strengthens Zimmer Biomet's foot and ankle segment, a ~$5B market growing high-single digits.
- Leverages Paragon 28's dedicated sales channel to accelerate ASC penetration and global growth.
- Transaction expected to accelerate Zimmer Biomet's weighted-average market growth rate (WAMGR).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525087219/0001193125-25-087219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525087219/d947892d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-087219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer